- Report
- November 2023
- 175 Pages
Global
From €4815EUR$5,000USD£4,141GBP
Paraplatin is a chemotherapy drug used to treat lung cancer. It is a combination of cisplatin and para-aminohippurate, and is used to treat non-small cell lung cancer (NSCLC). It is administered intravenously and works by interfering with the growth of cancer cells. Side effects of Paraplatin include nausea, vomiting, hair loss, and anemia.
Paraplatin is one of several drugs used to treat lung cancer. Other drugs used to treat NSCLC include Taxol, Alimta, and Gemzar. These drugs are used in combination with radiation therapy and/or surgery to treat the disease.
The Paraplatin market is highly competitive, with several major pharmaceutical companies offering the drug. Companies in the market include Pfizer, Bristol-Myers Squibb, AstraZeneca, and Eli Lilly. Show Less Read more